ArticleNeuroscience applied2024
GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling.
Karlijn L Kooij et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it